
Axcella Health AXLA
Quarterly report 2023-Q2
added 08-03-2023
Axcella Health P/CF Ratio 2011-2026 | AXLA
Annual P/CF Ratio Axcella Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.359 | -1.2 | -4.02 | -1.58 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.359 | -4.02 | -1.79 |
P/CF Ratio of other stocks in the Biotechnology industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
-1.71 | - | 10.36 % | $ 9.8 M | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Ascendis Pharma A/S
ASND
|
-17.6 | $ 219.89 | 2.02 % | $ 5 B | ||
|
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | ||
|
Omeros Corporation
OMER
|
-3.21 | $ 10.41 | 2.26 % | $ 606 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
8 | $ 19.54 | 1.61 % | $ 913 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
Atreca
BCEL
|
-0.607 | - | -11.76 % | $ 5.79 M | ||
|
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
-0.285 | - | - | $ 546 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Cara Therapeutics
CARA
|
-0.588 | - | -3.03 % | $ 260 M | ||
|
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
Processa Pharmaceuticals
PCSA
|
-0.363 | $ 2.33 | - | $ 3.05 M | ||
|
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
-2.05 | $ 1.32 | - | $ 337 M | ||
|
Phathom Pharmaceuticals
PHAT
|
-5.91 | $ 10.41 | 3.48 % | $ 759 M | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
-1.97 | $ 8.29 | 1.28 % | $ 110 M | ||
|
CRISPR Therapeutics AG
CRSP
|
-12.7 | $ 47.2 | 1.66 % | $ 4.24 B | ||
|
Cyclacel Pharmaceuticals
CYCC
|
-0.698 | - | -5.98 % | $ 34.1 M | ||
|
ChemoCentryx
CCXI
|
-0.024 | - | - | $ 3.74 B | ||
|
Dynavax Technologies Corporation
DVAX
|
26 | - | - | $ 2.02 B | ||
|
BioDelivery Sciences International
BDSI
|
7.5 | - | -4.8 % | $ 255 M | ||
|
Enochian Biosciences
ENOB
|
-14.7 | - | - | $ 40.5 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | ||
|
Pliant Therapeutics
PLRX
|
-0.636 | $ 1.31 | 1.95 % | $ 80.4 M | ||
|
PMV Pharmaceuticals
PMVP
|
-1.16 | $ 1.38 | -1.08 % | $ 72.5 M | ||
|
Bellerophon Therapeutics
BLPH
|
-4.42 | - | -74.18 % | $ 955 K | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
-21.4 | $ 4.46 | 3.48 % | $ 855 M | ||
|
Homology Medicines
FIXX
|
-0.672 | - | 0.77 % | $ 53.4 M | ||
|
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | ||
|
AIkido Pharma
AIKI
|
-1.3 | - | 1.93 % | $ 17.4 M | ||
|
Prelude Therapeutics Incorporated
PRLD
|
-4.92 | $ 3.28 | 4.97 % | $ 252 M |